These data support previous findings that the unbalanced and constant phosphorylation of MYPT1 at Thr853 was suggested to be related to cancer formation and mutations, as well as altered phosphorylation and expression of MYPT1 were documented in various cancer types [47,48]. This evidence concerns the gene PPP1R12A and cancer.